Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.

about

Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.

Item

http://www.wikidata.org/entity/Q47448408

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Glycoprotein Non-Metastatic Me ...... Potential Therapeutic Target.

@en

Glycoprotein Non-Metastatic Melanoma Protein B

@nl

type

Item

label

Glycoprotein Non-Metastatic Me ...... Potential Therapeutic Target.

@en

Glycoprotein Non-Metastatic Melanoma Protein B

@nl

prefLabel

Glycoprotein Non-Metastatic Me ...... Potential Therapeutic Target.

@en

Glycoprotein Non-Metastatic Melanoma Protein B

@nl

P1476

Glycoprotein Non-Metastatic Me ...... Potential Therapeutic Target.

@en

P2093

Manisha Taya

http://www.w3.org/2001/XMLSchema#string

Stephen R Hammes

http://www.w3.org/2001/XMLSchema#string

P2860

Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function

nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts

ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties

The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer

Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis

Osteoactivin promotes breast cancer metastasis to bone

Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer

P31

scholarly article

P356

10.1016/J.STEROIDS.2017.10.013

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29097143

http://www.w3.org/2001/XMLSchema#string

P932

6166407

http://www.w3.org/2001/XMLSchema#string